1. Congratulations to BoardProspects Member Michal Preminger on Her Appointment to the Board of Compugen (NASDAQ: CPGN)!

    Congratulations to BoardProspects Member Michal Preminger on Her Appointment to the Board of Compugen (NASDAQ: CPGN)!

    BoardProspects would like to congratulate Member Michal Preminger on her appointment to the Board of Directors of Compugen (NASDAQ: CPGN).  Dr. Preminger is the Executive Director at Harvard University Office of Technology Development's Harvard Medical School site.  Dr. Preminger is also a member of the board of directors of BioArray Genetics and Israel Brain Technologies, and a member of the Scientific Advisory Board at FutuRx (a partnership between Takeda Pharmaceuticals, Johnson & Johnson and Orbimed Ventures) and Prize4Life.

    Compugen is a genomics-based drug and diagnostic discovery company.

     

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned